ALGINATE FIBER

K914779 · Adri/Technam · NAC · Dec 4, 1991 · General, Plastic Surgery

Device Facts

Record IDK914779
Device NameALGINATE FIBER
ApplicantAdri/Technam
Product CodeNAC · General, Plastic Surgery
Decision DateDec 4, 1991
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4018
Device ClassClass 1

Device Story

Alginate Fiber is a hydrophilic wound dressing. It is applied topically to manage wounds. The device functions as a dressing to cover and protect wounds. It is intended for use by healthcare providers or patients in clinical or home settings. The device does not claim to accelerate healing, treat vascular stasis ulcers, or serve as artificial skin/long-term dressing without further FDA approval.

Clinical Evidence

No clinical data provided.

Technological Characteristics

Hydrophilic wound dressing composed of alginate fiber. Classified as Class I under 21 CFR 878.4018 (Product Code NAC).

Regulatory Classification

Identification

A hydrophilic wound dressing is a sterile or non-sterile device intended to cover a wound and to absorb exudate. It consists of nonresorbable materials with hydrophilic properties that are capable of absorbing exudate (e.g., cotton, cotton derivatives, alginates, dextran, and rayon). This classification does not include a hydrophilic wound dressing that contains added drugs such as antimicrobial agents, added biologics such as growth factors, or is composed of materials derived from animal sources.

Submission Summary (Full Text)

{1} ![LOGO](FDA U.S. FOOD & DRUG ADMINISTRATION) April 9, 2024 ADRI/Technam George H. Scherr, Ph.D. Director P.O. Box 134 Park Forest, Illinois 60466 Re: K914779 Trade/Device Name: Alginate Fiber Regulation Number: 21 CFR 878.4018 Regulation Name: Hydrophilic wound dressing Regulatory Class: Class I Product Code: NAC Dear George H. Scherr, Ph.D.: The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated December 4, 1991. Specifically, FDA is updating this SE Letter because FDA has better categorized your device technology under product code NAC. Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Yu-Chieh Chiu, OHT4: Office of Surgical and Infection Control Devices, 301-796-6196, yu-chieh.chiu@fda.hhs.gov. Sincerely, Yu-chieh Chiu -S Yu-Chieh Chiu, Ph.D. Assistant Director DHT4B: Division of Infection Control and Plastic Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service DEC -4 1991 Food and Drug Administration 1390 Piccard Drive Rockville MD 20850 George H. Scherr, Ph.D. Director ADRI/Technam P.O. Box 134 Park Forest, Illinois 60466 Re: K914779 Alginate Fiber Regulatory Class: Unclassified Dated: November 7, 1991 Received: November 14, 1991 Dear Dr. Scherr: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. You may, therefore, market your device subject to the general controls provisions of the Federal Food, Drug, and Cosmetic Act (Act) and the following limitations: 1. This device may not be labeled for use on third degree burns without specific Food and Drug Administration (FDA) approval for such labeling. 2. This device may not be labeled as having any accelerating effect on the rate of wound healing or epithelization without evidence of said effect being reviewed and approved by FDA. 3. This device may not be labeled as a long-term or permanent, no change dressing, or as an artificial or synthetic skin without specific FDA approval for such labeling. 4. This device may not be labeled as a treatment or a cure for vascular stasis ulcers without specific FDA approval for such labeling. The general controls provisions of the Act include requirements for registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration. 000001 {3} Page 2 - Dr. George H. Scherr If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under the Radiation Control for Health and Safety Act of 1968, or other Federal Laws or Regulations. This letter immediately will allow you to begin marketing your device as described. An FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market, but it does not mean that FDA approves your device. Therefore, you may not promote or in any way represent your device or its labeling as being approved by FDA. If you desire specific advice on the labeling for your device please contact the Division of Compliance Operations, Regulatory Guidance Branch (HFZ-323) at (301) 427-1116. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at their toll free number (800) 638-2041 or at (301) 443-6597. Sincerely yours, Carl A. Larson Carl A. Larson, Ph.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health 000002
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...